Tara Arvedson

Company: Hexagon Bio

Job title: Chief Scientific Officer

Seminars:

Discovery of Novel ADC Payloads to Combat Topo1 & Tubulin Inhibitor Resistant Tumors 9:45 am

Assessing preclinical data for protein translation inhibitor payload demonstrating efficacy in tumors resistant to Topo1 and tubulin ADCs Learning about a discovery platform for natural product payloads with novel modes of action Discussing potential of other pipeline natural products for ADCsRead more

day: Conference Day Two